Sartorius Stedim Biotech SA Stock price Euronext Paris
Equities
STDM
FR0000053266
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- EUR | 0.00% |
Mar. 26 | Transcript : Sartorius Stedim Biotech S.A. - Shareholder/Analyst Call | |
Mar. 12 | SARTORIUS STEDIM BIOTECH : Jefferies remains its Buy rating | ZD |
Sales 2024 * | 3B 3.24B | Sales 2025 * | 3.44B 3.71B | Capitalization | 25.72B 27.71B |
---|---|---|---|---|---|
Net income 2024 * | 359M 387M | Net income 2025 * | 497M 535M | EV / Sales 2024 * | 9.57 x |
Net Debt 2024 * | 3.03B 3.27B | Net Debt 2025 * | 2.79B 3B | EV / Sales 2025 * | 8.28 x |
P/E ratio 2024 * |
69.6
x | P/E ratio 2025 * |
50.6
x | Employees | - |
Yield 2024 * |
0.29% | Yield 2025 * |
0.39% | Free-Float | 31.97% |
Latest transcript on Sartorius Stedim Biotech SA
Managers | Title | Age | Since |
---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 48 | 19-03-25 |
Chairman | 58 | 07-06-28 | |
Chief Tech/Sci/R&D Officer | 59 | 09-04-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Henri Riey
BRD | Director/Board Member | 62 | 07-06-28 |
Chairman | 58 | 07-06-28 | |
Susan Dexter
BRD | Director/Board Member | 67 | 15-04-06 |
1st Jan change | Capi. | |
---|---|---|
+3.26% | 197B | |
+5.79% | 115B | |
+1.48% | 71.22B | |
+11.77% | 53.77B | |
+18.31% | 48.75B | |
+6.41% | 44.22B | |
+12.38% | 28.85B | |
+9.76% | 28.57B | |
+18.02% | 27.62B |
- Stock
- Equities
- Stock Sartorius Stedim Biotech
- Stock Sartorius Stedim Biotech SA - Euronext Paris